Analysts gave the Cassava Sciences, Inc. (SAVA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2. If we narrow down to specifics, the data shows that none out of 4 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended SAVA as a Hold, 4 felt it is a Buy and none rated the stock as Underweight. Cassava Sciences, Inc.’s EPS for the current quarter is expected to be -$0.1.
Cassava Sciences, Inc. (NASDAQ:SAVA) trade information
Although SAVA has turned red as seen at the end of in last trading. With action -4.49%, the performance over the past five days has been red. The jump to weekly highs of $55.25 on Tuesday, Mar 23 added 19.49% to the stock’s daily price. The company’s shares are showing year-to-date upside of 5.52%, with the 5-day performance at -0.2% in the red. However, in the 30-day time frame, Cassava Sciences, Inc. (NASDAQ:SAVA) is -0.08% down. Looking at the short shares, we see there were 3.65 Million shares sold at short interest cover period of 0.49 days.
The consensus price target for the stock as assigned by Wall Street analysts is $90, meaning bulls need an upside of 102.34% from its current market value. According to analyst projections, SAVA’s forecast low is $73 with $110 as the target high. To hit the forecast high, the stock’s price needs a +147.3% upsurge from its current level, while the stock would need to tank 64.12% for it to hit the projected low.
Cassava Sciences, Inc. (SAVA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 35.4%. The 2021 estimates are for Cassava Sciences, Inc. earnings to increase by 8.8%, but the outlook for the next 5-year period is at 0% per year.
Cassava Sciences, Inc. (NASDAQ:SAVA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.2% of Cassava Sciences, Inc. shares while 26.51% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 28.88%. There are 95 institutions holding the Cassava Sciences, Inc. stock share, with Blackrock Inc. the top institutional holder. As of Dec 30, 2020, the company held 4.94% of the shares, roughly 1.97 Million SAVA shares worth $13.44 Million.
Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 3.97% or 1.58 Million shares worth $10.8 Million as of Dec 30, 2020.
Among Mutual Funds, the top two as of Dec 30, 2020 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 890577 shares estimated at $6.07 Million under it, the former controlled 2.23% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2% of the shares, roughly 799.51 Thousand shares worth around $38.84 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.